168 related articles for article (PubMed ID: 15195116)
1. Long-term preservation of antigenicity on tissue microarrays.
DiVito KA; Charette LA; Rimm DL; Camp RL
Lab Invest; 2004 Aug; 84(8):1071-8. PubMed ID: 15195116
[TBL] [Abstract][Full Text] [Related]
2. Loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer.
Jacobs TW; Prioleau JE; Stillman IE; Schnitt SJ
J Natl Cancer Inst; 1996 Aug; 88(15):1054-9. PubMed ID: 8683636
[TBL] [Abstract][Full Text] [Related]
3. Variability of immunohistochemical reactivity on stored paraffin slides.
Bertheau P; Cazals-Hatem D; Meignin V; de Roquancourt A; Vérola O; Lesourd A; Séné C; Brocheriou C; Janin A
J Clin Pathol; 1998 May; 51(5):370-4. PubMed ID: 9708203
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of methods for preserving PTEN antigenicity in stored paraffin sections.
Gelb AB; Freeman VA; Astrow SH
Appl Immunohistochem Mol Morphol; 2011 Dec; 19(6):569-73. PubMed ID: 21552118
[TBL] [Abstract][Full Text] [Related]
5. Antigenicity testing by immunohistochemistry after tissue oxidation.
Blind C; Koepenik A; Pacyna-Gengelbach M; Fernahl G; Deutschmann N; Dietel M; Krenn V; Petersen I
J Clin Pathol; 2008 Jan; 61(1):79-83. PubMed ID: 17412873
[TBL] [Abstract][Full Text] [Related]
6. Epitope Preservation Methods for Tissue Microarrays: Longitudinal Prospective Study.
Andeen NK; Bowman R; Baullinger T; Brooks JM; Tretiakova MS
Am J Clin Pathol; 2017 Nov; 148(5):380-389. PubMed ID: 29106459
[TBL] [Abstract][Full Text] [Related]
7. Loss of antigenicity in stored sections of breast cancer tissue microarrays.
Fergenbaum JH; Garcia-Closas M; Hewitt SM; Lissowska J; Sakoda LC; Sherman ME
Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):667-72. PubMed ID: 15066936
[TBL] [Abstract][Full Text] [Related]
8. Loss of antigenicity with tissue age in breast cancer.
Combs SE; Han G; Mani N; Beruti S; Nerenberg M; Rimm DL
Lab Invest; 2016 Mar; 96(3):264-9. PubMed ID: 26568292
[TBL] [Abstract][Full Text] [Related]
9. Storage Conditions and Immunoreactivity of Breast Cancer Subtyping Markers in Tissue Microarray Sections.
Omilian AR; Zirpoli GR; Cheng TD; Yao S; Stein L; Davis W; Head KL; Nair P; Khoury T; Ambrosone CB; Bshara W
Appl Immunohistochem Mol Morphol; 2020 Apr; 28(4):267-273. PubMed ID: 31205070
[TBL] [Abstract][Full Text] [Related]
10. Prognostic potential of automated Ki67 evaluation in breast cancer: different hot spot definitions versus true global score.
Robertson S; Acs B; Lippert M; Hartman J
Breast Cancer Res Treat; 2020 Aug; 183(1):161-175. PubMed ID: 32572716
[TBL] [Abstract][Full Text] [Related]
11. [How Long Are Unstained Sections Available for Immunostaining? -A Study of Antigenicity Preservation Time-].
Inoue S; Matsuki Y; Mori M
Rinsho Byori; 2016 Nov; 64(11):1215-1219. PubMed ID: 30695301
[TBL] [Abstract][Full Text] [Related]
12. Fresh Cut Versus Stored Cut Paraffin-embedded Tissue: Effect on Immunohistochemical Staining for Common Breast Cancer Markers.
Forse CL; Pinnaduwage D; Bull SB; Mulligan AM; Andrulis IL
Appl Immunohistochem Mol Morphol; 2019 Mar; 27(3):231-237. PubMed ID: 29553968
[TBL] [Abstract][Full Text] [Related]
13. Immunostaining of estrogen receptor, progesterone receptor, MIB1 antigen, and c-erbB-2 oncoprotein in cytologic specimens: a simplified method with formalin fixation.
Suthipintawong C; Leong AS; Chan KW; Vinyuvat S
Diagn Cytopathol; 1997 Aug; 17(2):127-33. PubMed ID: 9258620
[TBL] [Abstract][Full Text] [Related]
14. Stability of oestrogen and progesterone receptor antigenicity in formalin-fixed paraffin-embedded breast cancer tissue over time.
Ehinger A; Bendahl PO; Rydén L; Fernö M; Alkner S
APMIS; 2018 Sep; 126(9):746-754. PubMed ID: 30160021
[TBL] [Abstract][Full Text] [Related]
15. Strategies for improving the immunohistochemical staining of various intranuclear prognostic markers in formalin-paraffin sections: androgen receptor, estrogen receptor, progesterone receptor, p53 protein, proliferating cell nuclear antigen, and Ki-67 antigen revealed by antigen retrieval techniques.
Taylor CR; Shi SR; Chaiwun B; Young L; Imam SA; Cote RJ
Hum Pathol; 1994 Mar; 25(3):263-70. PubMed ID: 7512074
[TBL] [Abstract][Full Text] [Related]
16. Quality Assessment of Proteins and RNA Following Storage in Archival Formalin-Fixed Paraffin-Embedded Human Breast Cancer Tissue Microarray Sections.
Kim K; Ylaya K; Perry C; Lee MY; Kim JW; Chung JY; Hewitt SM
Biopreserv Biobank; 2023 Oct; 21(5):493-503. PubMed ID: 36264172
[TBL] [Abstract][Full Text] [Related]
17. Factors affecting immunoreactivity in long-term storage of formalin-fixed paraffin-embedded tissue sections.
Grillo F; Pigozzi S; Ceriolo P; Calamaro P; Fiocca R; Mastracci L
Histochem Cell Biol; 2015 Jul; 144(1):93-9. PubMed ID: 25757745
[TBL] [Abstract][Full Text] [Related]
18. Comparison of two methods of storing breast fine needle aspirates (FNAs) using oestrogen receptor immunocytochemical assay as a method of evaluating the storage methods.
Burton SA; Dowsett M; Trott PA
Cytopathology; 1994 Dec; 5(6):380-3. PubMed ID: 7880971
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of estrogen receptor heterogeneity in breast cancer.
Chung GG; Zerkowski MP; Ghosh S; Camp RL; Rimm DL
Lab Invest; 2007 Jul; 87(7):662-9. PubMed ID: 17334408
[TBL] [Abstract][Full Text] [Related]
20. Comparison of p53 immunoreactivity in fresh-cut versus stored slides with and without microwave heating.
Shin HJ; Kalapurakal SK; Lee JJ; Ro JY; Hong WK; Lee JS
Mod Pathol; 1997 Mar; 10(3):224-30. PubMed ID: 9071730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
